| Date | Title | Description |
| 06.05.2025 | Healx Appoints Christopher Moertel, M.D., as Global Head of Clinical Development | Dr Chris Moertel joins Healx as Global Head of Clinical Development
Healx, a leading AI-driven drug discovery company focused on rare diseases, announces Christopher Moertel, M.D., as Global Head of Clinical Development
We are thrilled to w... |
| 24.10.2024 | Innovate Cambridge launches strategy to accelerate innovation through increased startup investment | Cambridge, UK has unveiled a plan to supercharge the impact of the Greater Cambridge area by doubling the rate at which it builds unicorns, doubling the venture capital investment the city’s startups receive, and creating twice as many scie... |
| 06.09.2024 | August 2024's top 10 European tech deals you need to know about | August was the slowest month YTD, with over €1.9 billion raised in some 203 deals. This figure represents a decrease of around 60 per cent compared to the previous month (in July European tech companies collected €5 billion).
The August slo... |
| 08.08.2024 | Healx Secures $47 Million to Tackle Rare Diseases with AI Innovations | In a significant leap for the biotech sector, Healx, a clinical-stage company based in Cambridge, UK, has successfully raised $47 million in a Series C funding round. This infusion of capital is not just a financial boost; it’s a lifeline f... |
| 07.08.2024 | Healx: Clinical-Stage Biotech Company Secures $47 Million In Series C | Healx, an AI-enabled, clinical-stage biotech company specializing in rare diseases, announced it has raised $47 million in a Series C round. This Series C round was co-led by Silicon Valley-based R42 Group and Atomico, one of Europe’s large... |
| 09.02.2022 | Healx and Ovid Therapeutics enter strategic partnership | Healx and Ovid Therapeutics enter strategic partnership
09-02-2022
New York, NY and Cambridge, UK Ovid Therapeutics, a biopharmaceutical company committed to developing medicines that transform the lives of people with neurological diseases... |
| 21.11.2021 | Europe’s AI laws will cost companies a small fortune – but the payoff is trust | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Artificial intelligence isn’t tomorrow’s technolo... |
| 21.11.2021 | Europe’s AI laws will cost companies a small fortune – but the payoff is trust | Did you miss a session from the Future of Work Summit? Head over to our Future of Work Summit on-demand library to stream.
Artificial intelligence isn’t tomorrow’s technology — it’s already here. Now too is the legislation proposing to regu... |
| 22.10.2021 | Healx receives IND and Orphan Drug Designation for fragile X clinical trial | Healx receives IND and Orphan Drug Designation for fragile X clinical trial
22-10-2021
Healx has received Investigational New Drug (IND) approval from the US Food and Drug Administration (FDA) for the Phase 2a clinical study of the compound... |
| 22.10.2021 | Healx receives IND and Orphan Drug Designation for fragile X clinical trial | Healx has received Investigational New Drug (IND) approval from the US Food and Drug Administration (FDA) for the Phase 2a clinical study of the compound HLX-0201 for Fragile X syndrome. The clinical study will attempt to find at least one ... |
| 20.10.2021 | UK startup Healx to begin clinical trial on repositioned drug for Fragile X syndrome | There are currently no approved cures for Fragile X syndrome — the most common cause of inherited intellectual disability. At the moment, the treatments are designed to manage symptoms, from anxiety to OCD or, in rare cases, seizures. But a... |
| 12.08.2021 | Healx launches AI-powered indication expansion partnership with Ono Pharmaceutical | Healx launches AI-powered indication expansion partnership with Ono Pharmaceutical
12-08-2021
Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, today announced an exciting partnersh... |
| 12.08.2021 | Healx launches AI-powered indication expansion partnership with Ono Pharmaceutical | Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, today announced an exciting partnership with Ono Pharmaceutical Co Ltd, one of Japan’s largest pharmaceutical companies and a globa... |
| 30.06.2021 | Tech.eu Podcast: How to treat rare diseases with existing drugs — with Meri Williams, CTO of Healx | The Tech.eu Podcast is a show in which we discuss some of the most interesting stories from the European technology scene and interview leading entrepreneurs and investors from across the region.
In today’s episode, listen to an interview w... |
| 23.06.2021 | International Women in Engineering Day: Inspiration, Challenges and Future Opportunities | International Women in Engineering Day (IWED) serves as a potent reminder of how far the sector has evolved, with a recent report showing that 31% of UK tech jobs are now held by women.
As we look to celebrate International Women in Enginee... |
| 10.05.2021 | The most promising deep tech startups of Cambridge in 2021 | According to this report by Tech Nation, Cambridge is positioned among one of the eight cities in the UK with a higher digital density than the average The city is home to some of the fastest-growing tech companies in the UK such as Darktra... |
| 28.04.2021 | Healx appoints ex-Dyson and GCHQ as new VP of AI | Healx appoints ex-Dyson and GCHQ as new VP of AI
28-04-2021
Healx, the AI-powered, patient-inspired technology company accelerating the discovery and development of rare disease treatments at scale, is thrilled to announce that Andrew Watso... |
| 09.04.2021 | Healx launches partnership with Ataxia UK and FARA to find treatments for rare neurodegenerative condition | Healx launches partnership with Ataxia UK and FARA to find treatments for rare neurodegenerative condition
09-04-2021
Healx, the AI-powered, patient-inspired technology company accelerating the discovery and development of rare disease trea... |
| 09.04.2021 | Healx launches partnership with Ataxia UK and FARA to find treatments for rare neurodegenerative condition | Healx, the AI-powered, patient-inspired technology company accelerating the discovery and development of rare disease treatments at scale, is excited to announce its latest patient group partnerships.
Working in collaboration with Ataxia UK... |
| 09.03.2021 | Healx and the PKD Charity collaborate to apply AI to the discovery of novel treatments for rare kidney diseases | Healx and the PKD Charity collaborate to apply AI to the discovery of novel treatments for rare kidney diseases
09-03-2021
Healx, the AI-powered, patient-inspired technology company accelerating the discovery and development of rare disease... |
| 14.01.2021 | Five tips for growing your business and retaining an all-star team in 2021 | Five tips for growing your business and retaining an all-star team in 2021
14-01-2021
In Healx's latest blog, Co-Founder and CEO, Tim Guilliams shares his top tips for not just growing but retaining an all-star team this year.
Tim writes...... |
| 07.12.2020 | How to onboard teams and build strong connections with distributed working | How to onboard teams and build strong connections with distributed working
07-12-2020
In the first of Healx's new blog series, Senior Director of People, Leigh-Anne Jansen van Rensburg, explores the ways in which Healx has adapted its onboa... |
| 21.09.2020 | Tech.eu Podcast #187: Nvidia + Arm, Klarna’s funding, interview with Meri Williams of Healx | The Tech.eu Podcast is a show in which we discuss some of the most interesting stories from the European technology scene and interview leading entrepreneurs and investors from across the region.
This week, we talk about some of the biggest... |
| 18.09.2020 | Business Weekly Awards 2020 | Frontier Developments named Business of the Year
Article by Tony Quested | Business Weekly
Frontier Developments, Cambridge’s world-leading video games developer is today unveiled as Business of the Year in the toughest competition in 30 ye... |
| 17.06.2020 | Meri Williams joins Healx as Chief Technology Officer | Meri Williams joins Healx as Chief Technology Officer
17-06-2020
Experienced tech leader Meri Williams joins Healx - the AI-powered, patient-inspired technology company - from challenger bank Monzo, as Chief Technology Officer.
In her new r... |
| 20.04.2020 | COVID-19 takes toll on global M&A as $1b deals disappear | Premium
For the first time since September 2004, no merger and acquisition deal worth more than $1 billion was announced worldwide last week, according to data provider Refinitiv, as the new coronavirus stifles global M&A.
Continue read... |
| 19.03.2020 | Interview with Dr Tim Guilliams, CEO and co-founder of Healx | 0 shares
Share
Tweet
Pin
LinkedIn
Healx is a MedTech firm based in Cambridge, UK, founded in 2014 by Dr David Brown, co-creator of Viagra, and biochemical engineer Dr Tim Guilliams.
Healx aim to advance 100 treatments towards the clinic... |
| 17.03.2020 | Announcing: the UK companies joining Future Fifty 8.0 | Today we are delighted to welcome the new additions to our programme for late-stage tech companies. The prestigious Future Fifty.
The longest-running and most successful accelerator programme for late-stage tech companies in Europe, Future... |
| 12.03.2020 | Cofinitive shortlisted in 30th Anniversary Business Weekly Awards | Cofinitive shortlisted in 30th Anniversary Business Weekly Awards
12-03-2020
Cofinitive are delighted to announce that they have been shortlisted in the upcoming Business Weekly Awards.
The shortlist has listed us as “a growing team of comm... |
| 09.12.2019 | Early-stage cancer biotech nails $85M C round; Flemming Ornskov's Galderma scores 'breakthrough' status | → Zentalis Pharmaceuticals just nabbed an $85 million round from a syndicate that includes Matrix Capital, Viking Global Investors, Redmile Group, Farallon Capital, Perceptive Advisors, Surveyor Capital and Even... |
| 29.11.2019 | Who raised funding in Europe this week? Celonis, Bokio, Healx & more! | Undoubtedly, Europe is home to some of the bustling tech startup hubs in the world. With startup culture surging, Europe is regaining its lost ground by upping its game, not only in terms of innovation but with funding as well.
In this rega... |
| 21.11.2019 | Healx commits $20m to launch Rare Treatment Accelerator programme; appoints Dr Bruce Bloom as Chief Collaboration Officer to lead initiative | Healx commits $20m to launch Rare Treatment Accelerator programme; appoints Dr Bruce Bloom as Chief Collaboration Officer to lead initiative
21-11-2019
Healx, the AI-powered and patient-inspired technology company specialising in treatments... |
| 08.11.2019 | Research: October Health IT M&A Activity, Public Company Performance | – Healthcare Growth Partners (HGP) summary of Health IT/digital health merger & acquisition (M&A) activity, and public company performance during the month of October 2019
During the month of October, Health IT continued its evoluti... |
| 06.11.2019 | Michale Bouskila-Chubb recognised in 50 Movers and Shakers in BioBusiness Report | Michale Bouskila-Chubb recognised in 50 Movers and Shakers in BioBusiness Report
06-11-2019
Healx is delighted to announce that its Head of Business Development, Michale Bouskila-Chubb has been featured in the sixth annual Movers and Shaker... |
| 17.10.2019 | This UK startup uses AI to treat rare diseases quickly | The traditional drug discovery model, which is meant to treat rare diseases takes over a decade and consumes a huge investment. This is where the advancement of technology comes to play and makes it beneficial for patients by coming up with... |
| 16.10.2019 | Healx raises $56M Series B to use AI to find treatments for rare diseases | Healx, a Cambridge, U.K.-based startup using AI to help discover new treatments for rare diseases, has raised $56 million in Series B funding.
Leading the round is London-base VC firm Atomico, with participation by Intel Capital, Global Bra... |
| 16.10.2019 | Healx raises $56 million to combat rare diseases with AI | Healx, a company using artificial intelligence (AI) to discover new drug treatments for rare diseases, has raised $56 million in a series B round of funding led by Atomico, with participation from Intel Capital, Balderton Capital, Global Br... |
| 16.10.2019 | Healx gets $56 million Series B to find treatments for the world’s rare diseases | Cambridge-based Healx, an AI-powered biotech company researching treatments for rare diseases, has raised a $56 million Series B led by Atomico, joined by Intel Capital, Global Brain and btov Partners. The investment enables the company to ... |
| 16.10.2019 | Healx Raises $56M in Series B Financing | Healx, a Cambridge, UK-based AI-powered and patient-inspired technology company specializing in treatments for rare diseases, raised $56M in Series B financing.
The round was led by Atomico with participation from Intel Capital, Global Brai... |
| 16.10.2019 | Cambridge-based medtech startup Healx raises €50.7 million in Series B funding, launches accelerator programme for rare diseases | Cambridge-based medtech startup Healx is on a mission to improve the lives of rare disease patients, of which there are roughly 350 million globally. The startup uses AI, machine learning and pharmacological expertise to accelerate the disc... |
| 16.10.2019 | Healx secures $56m in Series B financing, launches global accelerator programme for rare diseases | Healx, the AI-powered and patient-inspired technology company specialising in treatments for rare diseases, today announces that it has raised $56 million in a Series B financing round, led by one of Europe’s largest VC firms Atomico and jo... |
| 16.10.2019 | Healx raises $56 million to combat rare diseases with AI | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Healx, a company using artificial intelligence (A... |
| 16.10.2019 | Healx Nabs $56M to Expand AI-Driven Drug Discovery Platform for Rare Diseases | – UK startup Healx lands $56M, led by Atomico to build an AI-driven clinical-stage portfolio for rare diseases, including treatments for fragile X syndrome, the leading genetic cause of autism.
– Healx’s Rare Treatment Accelerator program i... |
| 16.10.2019 | Healx secures $56m in Series B financing, launches global accelerator programme for rare diseases | Healx secures $56m in Series B financing, launches global accelerator programme for rare diseases
16-10-2019
Healx, the AI-powered and patient-inspired technology company specialising in treatments for rare diseases, today announces that it... |
| 11.07.2019 | Dr Neil Thompson appointed CSO of Healx to spearhead drug discovery expansion | Dr Neil Thompson appointed CSO of Healx to spearhead drug discovery expansion
11-07-2019
Healx, the Cambridge (UK) technology company developing breakthrough treatments for rare diseases, is pleased to announce the appointment of Neil Thomp... |
| 17.06.2019 | Cambridge Startups: Ones to Watch in 2019 | 8 shares
Share
Tweet
Pin
LinkedIn
Like its sister Oxford, Cambridge is known for world-class education, innovation and research, so it’s not surprising that the city has established itself as one of the country’s most influential techn... |
| 27.02.2019 | Cofinitive shortlisted for International Trade Champion award at Business Weekly Awards | Cofinitive shortlisted for International Trade Champion award at Business Weekly Awards
27-02-2019
Cofinitive is delighted to announce it has been shortlisted among the brightest and best of elite Cambridge-based companies in the upcoming B... |
| 27.07.2018 | AI-based Healx raises $10 million for drug discovery | The company uses the HealNet database, which maps more than 1 billion disease, patient and drug interactions and was built and maintained using machine learning techniques. The company plans to use the Series A round to expand its team of s... |
| 27.07.2018 | Healx raises $10M to help repurpose drugs for rare diseases | The company uses AI and machine learning to find cures for diseases the big pharma cos are ignoring
One of the problems that arises when it comes to for profit healthcare is companies need a financial incentive to take care of patients. Tak... |
| 27.07.2018 | Term Sheet — Friday, July 27 | MO’ MONEY
Happy Friday, Term Sheet readers.
Paid Content Securing the enterprise without boundaries From ExtraHop
WeWork China currently has 20,000 members spanning nearly 40 locations across three cities. It plans to expand to six new citi... |
| 26.07.2018 | Healx raises $10m as investors back AI to find rare disease treatments faster | Healx, the Cambridge (UK) technology company developing breakthrough treatments for rare diseases, has announced a $10 million Series A funding round, led by Balderton Capital, Europe’s leading early-stage venture investor. Existing investo... |
| 26.07.2018 | Healx raises $10 million to find more rare disease treatments faster with AI | Healx, the Cambridge-based medtech startup developing breakthrough treatments for rare diseases, today announced a $10 million Series A funding round, led by Balderton Capital. Existing investors, Jonathan Milner and Amadeus Capital also pa... |
| 26.07.2018 | Rare Disease Treatment Developer Healx Secures $10M in Series A Funding | Healx, a Cambridge, UK-based developer of treatments for rare diseases, secured $10m in Series A funding.
The round was led by Balderton Capital with participation from Jonathan Milner and Amadeus Capital Partners. Balderton’s Suranga Chand... |
| 26.07.2018 | Healx raises $10m as investors back AI to find rare disease treatments faster | Healx raises $10m as investors back AI to find rare disease treatments faster
26-07-2018
Healx, the Cambridge (UK) technology company developing breakthrough treatments for rare diseases, has announced a $10 million Series A funding round, ... |
| 26.07.2018 | UK-based AI startup Healx raised $10 million to find rare disease treatments | Healx, a Cambridge-based medtech company that uses AI to discover and develop treatments for rare diseases, has announced a $10 million Series A funding round. The investment was led by Balderton Capital, with participation from existing in... |
| 06.10.2016 | Healx Raises £1.5M in Series A Funding | Healx, a Cambridge, UK-based healthcare company that seeks new uses for existing drugs in the fight against rare diseases, raised £1.5m in Series A funding.
The round was led by global technology investor Amadeus Capital Partners with parti... |
| 04.10.2016 | Healx secures £1.5m from Amadeus Capital and investors to combat rare diseases | Machine learning and advanced analytics help Healx identify new uses for existing drugs
Add This Share Buttons
Amadeus Capital Partners, the global technology investor, has made an early-stage investment in Healx, an innovative British heal... |
| 04.10.2016 | Healx secures £1.5m from Amadeus Capital and investors to combat rare diseases | Healx secures £1.5m from Amadeus Capital and investors to combat rare diseases
04-10-2016
Machine learning and advanced analytics help Healx identify new uses for existing drugs
Add This Share Buttons
Amadeus Capital Partners, the global te... |
| - | AI-based Healx raises $10 million for drug discovery | The researcher who invented Viagra and a colleague at Cambridge University have become the latest to join the ranks of drug developers using artificial intelligence and attracting attention from venture capitalists.
Cambridge, UK-based Heal... |
| - | Healx | - |
| - | Tech.eu Podcast: How to treat rare diseases with existing drugs — with Meri Williams, CTO of Healx | The Tech.eu Podcast is a show in which we discuss some of the most interesting stories from the European technology scene and interview leading entrepreneurs and investors from across the region.
In today’s episode, listen to an interview w... |
| - | Schrödinger: инвестиции в drug discovery и materials science. Есть ли перспективы после падения акций на 70%? | Для инвесторов в биотех и фармацевтические компании последний год выдался непростым. Популярный ETF SPDR S&P Biotech, он же XBI, состоящий в основном из биотехов малой и средней капитализации, потерял уже более 40% с пиковых значений в ... |
| - | Healx secures $56M Series B and launches global accelerator programme for rare diseases | The funding will be used to build a clinical-stage portfolio for rare diseases, including treatments for fragile X syndrome, the leading genetic cause of autism.
Where the traditional drug discovery model takes more than a decade and can r... |
| - | Healx raises $10M for AI technology that finds treatments for rare disease faster | Healx today announced their $10 million Series A funding round, led by Balderton Capital, with participation from existing investors Jonathan Milner and Amadeus Capital.
Read Suranga's thoughts behind the investment on his Medium, with the... |
| - | The most promising deep tech startups of Cambridge in 2021 | According to this report by Tech Nation, Cambridge is positioned among one of the eight cities in the UK with a higher digital density than the average The city is home to some of the fastest-growing tech companies in the UK such as Darktra... |
